163 related articles for article (PubMed ID: 34098104)
1. Palindromic rheumatism: Evidence of four subtypes of palindromic-like arthritis based in either MEFV or rheumatoid factor/ACPA status.
Cuervo A; Sanmartí R; Ramírez J; Castellanos-Moreira R; Inciarte-Mundo J; Aróstegui JI; McGonagle D; Cañete JD
Joint Bone Spine; 2021 Dec; 88(6):105235. PubMed ID: 34098104
[TBL] [Abstract][Full Text] [Related]
2. The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis.
Tani Y; Kishi T; Miyamae T; Kawamoto M; Kawaguchi Y; Taniguchi A; Yamanaka H
Clin Rheumatol; 2020 Mar; 39(3):841-845. PubMed ID: 31897954
[TBL] [Abstract][Full Text] [Related]
3. Correlation genotype-phenotype:
Missoum H; Adadi N; Alami M; Toufik H; Bouyahya A; Laarabi FZ; Bachir F; Maghraoui AE; Bakri Y
Pan Afr Med J; 2022; 41():121. PubMed ID: 35480407
[TBL] [Abstract][Full Text] [Related]
4. Relapsing periodic arthritis, palindromic rheumatism and MEFV gene-related variants alleles in children.
Salehzadeh F; Barak M; Nematdoust Haghi R
Pediatr Rheumatol Online J; 2019 Jun; 17(1):28. PubMed ID: 31171010
[TBL] [Abstract][Full Text] [Related]
5. Progression of palindromic rheumatism to juvenile idiopathic arthritis in a Japanese girl carrying heterozygous L110P-E148Q substitutions of MEFV gene.
Kobayashi I; Yamazaki Y; Tozawa Y; Ueki M; Takezaki S; Yamada M; Ariga T
Mod Rheumatol; 2018 Mar; 28(2):365-368. PubMed ID: 26457478
[TBL] [Abstract][Full Text] [Related]
6. An unexpectedly high frequency of MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism.
Cañete JD; Arostegui JI; Queiró R; Gratacós J; Hernández MV; Larrosa M; Alperí M; Moll C; Rius J; Sanmartí R; Yagüe J
Arthritis Rheum; 2007 Aug; 56(8):2784-8. PubMed ID: 17665427
[TBL] [Abstract][Full Text] [Related]
7. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
[TBL] [Abstract][Full Text] [Related]
8. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
[TBL] [Abstract][Full Text] [Related]
9. Components of treatment delay in rheumatoid arthritis differ according to autoantibody status: validation of a single-centre observation using national audit data.
Pratt AG; Lendrem D; Hargreaves B; Aslam O; Galloway JB; Isaacs JD
Rheumatology (Oxford); 2016 Oct; 55(10):1843-8. PubMed ID: 27373893
[TBL] [Abstract][Full Text] [Related]
10. Brief Report: Association of Rheumatoid Factor and Anti-Citrullinated Protein Antibody Positivity With Better Effectiveness of Abatacept: Results From the Pan-European Registry Analysis.
Gottenberg JE; Courvoisier DS; Hernandez MV; Iannone F; Lie E; Canhão H; Pavelka K; Hetland ML; Turesson C; Mariette X; Finckh A
Arthritis Rheumatol; 2016 Jun; 68(6):1346-52. PubMed ID: 26815727
[TBL] [Abstract][Full Text] [Related]
11. Differential response of the rheumatoid factor and anticitrullinated protein antibodies during adalimumab treatment in patients with rheumatoid arthritis.
Bos WH; Bartelds GM; Wolbink GJ; de Koning MH; van de Stadt RJ; van Schaardenburg D; Dijkmans BA; Nurmohamed MT
J Rheumatol; 2008 Oct; 35(10):1972-7. PubMed ID: 18785316
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials.
Aletaha D; Alasti F; Smolen JS
Arthritis Res Ther; 2015 Aug; 17(1):229. PubMed ID: 26307354
[TBL] [Abstract][Full Text] [Related]
13. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
14. Repeat serological testing for anti-citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis.
Reid AB; Wiese M; McWilliams L; Metcalf R; Hall C; Lee A; Hill C; Wechalekar M; Cleland L; Proudman SM
Intern Med J; 2020 Jul; 50(7):818-822. PubMed ID: 32656986
[TBL] [Abstract][Full Text] [Related]
15. Does information on novel identified autoantibodies contribute to predicting the progression from undifferentiated arthritis to rheumatoid arthritis: a study on anti-CarP antibodies as an example.
Boeters DM; Trouw LA; van der Helm-van Mil AHM; van Steenbergen HW
Arthritis Res Ther; 2018 May; 20(1):94. PubMed ID: 29724250
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism.
Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME
J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159
[TBL] [Abstract][Full Text] [Related]
17. ACPA Antibodies Titer at the Time of Rheumatoid Arthritis Diagnosis Is Not Associated with Disease Severity.
Shpatz R; Braun-Moscovici Y; Balbir-Gurman A
Isr Med Assoc J; 2021 Oct; 23(10):646-650. PubMed ID: 34672447
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort.
Mouterde G; Rincheval N; Lukas C; Daien C; Saraux A; Dieudé P; Morel J; Combe B
Arthritis Res Ther; 2019 Jun; 21(1):140. PubMed ID: 31171038
[TBL] [Abstract][Full Text] [Related]
19. Does immunological remission, defined as disappearance of autoantibodies, occur with current treatment strategies? A long-term follow-up study in rheumatoid arthritis patients who achieved sustained DMARD-free status.
Boeters DM; Burgers LE; Toes RE; van der Helm-van Mil A
Ann Rheum Dis; 2019 Nov; 78(11):1497-1504. PubMed ID: 31413004
[TBL] [Abstract][Full Text] [Related]
20. The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.
Ten Brinck RM; van Steenbergen HW; van Delft MAM; Verheul MK; Toes REM; Trouw LA; van der Helm-van Mil AHM
Rheumatology (Oxford); 2017 Dec; 56(12):2145-2153. PubMed ID: 28968865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
